Product Name | MF | CAS | Details |
---|
Dalmelitinib | C22H16FN7O2S | 1637658-98-0 | Details |
Syk Inhibitor II dihydrochloride dihydrate | C14H18ClF3N6O2 | 1965323-05-0 | Details |
HIV-1 inhibitor-42 | C22H20N2O5S | 2459929-46-3 | Details |
EIF2α activator 2 | C21H20F6N2O2 | 1501618-04-7 | Details |
Microtubule inhibitor 7 | C25H19FN2O5 | 2416338-65-1 | Details |
KVI-020 | C20H25N3O5S | 1000306-34-2 | Details |
JNc-440 | C26H24N4O3 | 1119503-63-7 | Details |
FLT3/ITD-IN-4 | C25H22N4O5 | 2278278-04-7 | Details |
TLR7 agonist 4 | C23H34N6O3 | 2413016-42-7 | Details |
BuChE-IN-1 | C23H23FN2O4S | 2669070-40-8 | Details |
Microtubule inhibitor 4 | C25H23FN4O3 | 2411962-64-4 | Details |
BET bromodomain inhibitor 2 | C23H30N2O5S | 2414195-69-8 | Details |
Aurora Kinases-IN-2 | C22H18ClN5O3 | 2241914-86-1 | Details |
AS-136A | C17H19F3N4O3S | 949898-66-2 | Details |
KRAS G12C inhibitor 29 | C23H21ClFN5O2 | 847337-63-7 | Details |
Lazuvapagon | C27H32N4O3 | 2379889-71-9 | Details |
Nur77 modulator 2 | C26H25NO5 | 2055829-03-1 | Details |
Y08175 | C23H19FN4O5 | 2223014-57-9 | Details |
Aurora A inhibitor 2 | C24H26N6O3 | 2412144-74-0 | Details |
HIV-1 inhibitor-33 | C25H28N6O | 2395777-43-0 | Details |
KRAS inhibitor-18 | C20H15ClF3N3O2S | 2230873-66-0 | Details |
HIV-1 inhibitor-24 | C26H19N5O2 | 2475658-75-2 | Details |
hGPR91 antagonist 3 | C23H18F4N4O2 | 1314796-31-0 | Details |
(Z)-Fluoxastrobin | C21H16ClFN4O5 | 887973-21-9 | Details |
VII-31 | C23H25NO5S | 2305757-96-2 | Details |
SHP504 | C23H15ClN4O4 | 2222280-83-1 | Details |
UNC9994 hydrochloride | C21H23Cl3N2OS | 2108826-33-9 | Details |
Myoferlin inhibitor 1 | C26H28N6O2 | 2366279-99-2 | Details |
Microtubule inhibitor 6 | C24H19FN2O5 | 2416338-64-0 | Details |
KRAS inhibitor-17 | C21H18Cl2FN3O2S | 2230873-65-9 | Details |
Rafutrombopag | C25H22N4O5 | 2600513-51-5 | Details |
POLA1 inhibitor 1 | C26H27NO4 | 2217671-41-3 | Details |
TRPC6-IN-3 | C22H22FN5O3 | 2311863-36-0 | Details |
FLT3-IN-15 | C22H23ClFN5O2 | 2435562-99-3 | Details |
Xininurad | C15H10Br2FN3O2 | 2365178-28-3 | Details |
CCR8 antagonist 2 | C23H30ClN3O3S | 2756350-98-6 | Details |
HIV-1 inhibitor-34 | C26H27N7O | 2395777-45-2 | Details |
Topoisomerase II inhibitor 4 | C25H25N5O4 | 2560590-49-8 | Details |
Raltegravir sodium | C20H22FN6NaO5 | 1292804-07-9 | Details |
TDP1 Inhibitor-2 | C25H14Cl2O5 | 859142-95-3 | Details |
GGTI-286 hydrochloride | C23H32ClN3O3S | 181141-66-2 | Details |
Carbonic anhydrase inhibitor 11 | C19H15F3N4O3S2 | 2411059-71-5 | Details |
PI3Kγ inhibitor 4 | C20H24N4O4S | 1821038-80-5 | Details |
OM-1700 | C25H23FN6O2 | 2406276-78-4 | Details |
AS1134900 | C25H22N8S | 149760-98-5 | Details |
FLT3-IN-11 | C20H25F3N6O | 2499966-50-4 | Details |
KRAS inhibitor-12 | C19H16Cl2FN5OS | 2230874-00-5 | Details |
CB1/2 agonist 2 | C26H43NO3 | 2772379-97-0 | Details |
GABAA receptor modulator-2 | C22H22FN3O5S | 2413850-54-9 | Details |
Haloperidol lactate | C24H29ClFNO5 | 53515-91-6 | Details |
TYK2-IN-12 | C24H20F2N4O2 | 2244061-66-1 | Details |
KRAS G12C inhibitor 53 | C21H14ClF2N5O2 | 2761968-93-6 | Details |
ERK1/2 inhibitor 7 | C23H22FN7OS | 2648455-13-2 | Details |
Senexin C | C28H27N5O | 2375554-02-0 | Details |
BRD4 Inhibitor-23 | C22H19F2N3O4S | 2760307-53-5 | Details |
Aurora kinase inhibitor-9 | C19H17Cl2N3O4S | 2419107-09-6 | Details |
IDH1 Inhibitor 5 | C26H34N4O3 | 1940128-37-9 | Details |
Lotrafiban | C23H32N4O4 | 171049-14-2 | Details |
SW02 | C19H23BrN2O5 | 1010820-68-4 | Details |
Posenacaftor | C27H27NO5 | 2095064-05-2 | Details |
MARK-IN-4 | C21H23N7OS | 1990492-86-8 | Details |
FLT3-IN-12 | C21H23F3N6O | 2499966-67-3 | Details |
Aha1/Hsp90-IN-1 | C22H17F3N4O2 | 2768265-58-1 | Details |
Estrogen receptor α antagonist 1 | C26H32N2O5 | 2580941-45-1 | Details |
BAY 2476568 | C24H27FN4O4 | 2311901-93-4 | Details |
HIV-1 inhibitor-25 | C26H19N5O2 | 2475658-74-1 | Details |
ALOX15-IN-2 | C23H29N3O4S | 2764818-23-5 | Details |
GNE-9278 | C21H27N5O3S | 2315311-83-0 | Details |
Panamesine | C23H26N2O6 | 139225-22-2 | Details |
Carbonic anhydrase inhibitor 7 | C23H17N3O5S | 546105-61-7 | Details |
KRAS inhibitor-15 | C20H17Cl2FN4OS | 2230873-75-1 | Details |
Vulolisib | C18H19F2N5O3S | 2390105-79-8 | Details |
KRAS inhibitor-16 | C20H16Cl2FN3O2S | 2230873-67-1 | Details |
Tubulin inhibitor 25 | C26H22O8 | 2411697-71-5 | Details |
NR2F6 modulator-1 | C23H17NO5S | 904449-84-9 | Details |
HIV-1 inhibitor-46 | C24H21ClN4OS | 332947-35-0 | Details |
ZY-444 | C26H28N4OS | 1802650-31-2 | Details |
Bromperidol hydrochloride | C21H24BrClFNO2 | 59453-24-6 | Details |
VVD-118313 | C19H22Cl2N2O3S | 2875046-27-6 | Details |
FabG1-IN-1 | C14H8Cl2INO3 | 1051177-61-7 | Details |
NN-390 | C17H16F4N2O4S | 2490284-25-6 | Details |
STAT3-IN-13 | C21H20N6O3S | 2248552-86-3 | Details |
PI3K/mTOR Inhibitor-9 | C23H27N7O2 | 1392421-71-4 | Details |
CDK7/12-IN-1 | C25H34N8O | 2654075-94-0 | Details |
GPR41 agonist-1 | C24H23N3O4 | 506417-09-0 | Details |
Microtubule inhibitor 3 | C26H23FN4O3 | 1236141-96-0 | Details |
Anticancer agent 32 | C24H21F2N5O | 2222930-76-7 | Details |
AMPK-IN-3 | C25H33N5O3 | 2417674-27-0 | Details |
ET-JQ1-OH | C21H21ClN4O2S | 2421153-77-5 | Details |
Anti-melanoma agent 1 | C28H28N2O2 | 2418579-17-4 | Details |
IHMT-MST1-58 | C21H22N6O3S | 2414484-25-4 | Details |
CJJ300 | C30H33N3 | 1807631-83-9 | Details |
GABAA receptor agent 2 TFA | C22H22F3N3O3 | 1781880-44-1 | Details |
MEIS-IN-1 | C24H21F3N2O4 | 2761326-82-1 | Details |
SGLT1/2-IN-1 | C25H28O8 | 1673514-65-2 | Details |
Sunobinop | C26H33N3O3 | 1126793-40-5 | Details |
Glucosylceramide synthase-IN-1 | C24H20F4N2O3 | 2601393-20-6 | Details |
Trk-IN-9 | C23H24ClFN6O | 2758623-12-8 | Details |
Topoisomerase I inhibitor 8 | C24H21FN2O4 | 210346-40-0 | Details |
RUSKI-201 dihydrochloride | C20H28ClN3OS | 2320262-09-5 | Details |
Product Total: Product Page: | ||||
76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 |